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The application of nanomaterials, containing particles 1000 times smaller than the 
thickness of a human hair, is increasing but uncertainties persist regarding their 
potential health effects. An ongoing study to identify where nanomaterials are used in 
construction and to assess the impact of demolition processes on particle release has 
identified difficulties which arise when dealing with the unknown: assessing, and 
managing the risks of these, and other, new materials. The widespread use of 
materials whose risks are inadequately understood is clearly unsatisfactory. However, 
the timing of a detailed health evaluation for a new product or process is not 
straightforward - a focus on these aspects too early in a developmental lifecycle may 
derail potentially promising innovations. It is also necessary to carefully balance 
benefit and risk. A product with moderate risk potential may be tolerated provided 
there are significant benefits, and adequate control measures are available. Questions 
also arise regarding who should carry out and fund health risk assessments for new 
materials. Manufacturers clearly have responsibilities, but there are also advantages in 
centrally funded, objective assessment. Particular complications arise when assessing 
the health risks for nanomaterials in view of their wide variability and the lack of 
adequate exposure data. There is no requirement to label nano-enabled building 
materials. This makes it difficult to assess the extent of their usage, and hence also to 
determine the health risks to those working with them, or exposed to them due to 
demolition or recycling at the end of the product or building life. Manufacturers, 
researchers, governments and wider society share responsibility for addressing these 
challenges. However, there are steps which constructors can take in the interim to 
minimise the impact on those working with these uncertainties. 
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INTRODUCTION 
Nanomaterials have one or more dimensions between 1 and 100 nm – for comparison, 
consider that a typical human hair is around 80,000 nm in diameter. Engineered 
nanomaterials (ENM) are those which have been intentionally produced, rather than 
occurring naturally or arising as a by-product (e.g. from volcanos or traffic pollution). 
They can offer exciting properties, sometimes very different from those of materials in 
their more usual ‘bulk’ form. For example, gold becomes soluble at the nanoscale and 
titanium dioxide, traditionally used for its whiteness, can appear transparent. 
Nanomaterials have been identified by the European Union as a Key Enabling 
Technology, important for future employment, financial growth and technical 
innovation. There are prospects of flexible phone screens, more efficient solar panels, 
and advances in lithium ion battery design. In medicine, there is potential for drugs to 
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target tumours directly without damaging surrounding tissues, to fight multiple 
sclerosis and maybe even to repair damaged spinal cords. In construction, 
nanomaterials (predominantly silicon dioxide and titanium dioxide) are found in ‘self-
cleaning’ windows, often used in conservatory roofs; in self-compacting concrete; and 
in water resistant coatings (van Broekhuizen and van Broekhuizen 2009). Other 
applications such as pavements which reduce airborne pollution are also being 
developed, although not yet in widespread use. 
Our ongoing project, sponsored by the UK’s Institution of Occupational Safety and 
Health (IOSH) is looking at the use of nanomaterials in the construction and 
demolition sectors. The main purpose of the study is to assess the health risks which 
may arise when buildings which have been built using ENM-enhanced products are 
demolished. We are addressing this by: 
 Developing a database of construction materials which are, or appear to be, 
nano-enabled 
 Assessing sample products using material characterisation techniques (such as 
scanning electron microscopy, and energy dispersive X ray spectroscopy) to 
identify whether they are nano-enabled and describe the nanomaterial used 
 Interviewing representatives from the construction and demolition sectors to 
understand where nano-enabled products might be used and also to identify the 
processes which will be used to demolish buildings at end of life 
 Laboratory replication of common demolition techniques to assess their impact 
on nano-enabled building products, and to explore the likelihood of 
nanoparticle release 
Our work has highlighted the difficulties of managing the health and safety risks of 
materials which are at a relatively early stage of development. In this paper we use 
examples from our research to explore these issues, many of which will arise when 
managing risks from novel materials and processes more widely. First, we discuss the 
challenges of assessing the hazard and exposure risk from nanomaterials. We then 
consider the need to balance benefit and risk. We address practical issues of risk 
assessment – including the timing of such assessment, and whose responsibility it 
should be to carry out appropriate hazard evaluation. Finally, we consider the 
importance of disseminating the right information to the right individuals. In each 
section, we suggest how these challenges might be addressed, including intervention 
at government or societal levels. We also consider how constructors can continue to 
manage their work safely despite the lack of clarity in some areas.  
A particular complication with nanotechnology is that there are many different 
definitions. Some discussions focus only on materials which contain nanoparticles. 
Alternate definitions encompass materials which have internal dimensions (spaces or 
pores) at the nanoscale even though they do not contain nanoparticles. Our research 
for this paper has taken a broad approach, considering any material which has some 
dimension at the nanoscale or which is described by the manufacturer as using 
nanotechnology.  
ASSESSING THE HAZARD FROM NANOMATERIALS  
Hazard relates to potential impact on workers, other people, and the wider 
environment – for new substances, the question is, ‘how toxic or dangerous is this 
material to those who may come into contact with it?’ A key concern about the health 
risk from nanomaterials relates to their relatively high surface area, which increases 
their reactivity. For example, non-nano titanium dioxide might have a surface area of 
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around 2m2/g, compared to nano titanium dioxide with a surface area of perhaps 
175m2/g depending on the particle size and structure (Xiong et al. 2013). Surface area 
however, is only one part of the equation, as there are substantial differences between 
materials in their toxicity. In fact, to talk about the health risk of ‘nanomaterials’ is no 
more meaningful than to refer in generic terms to the health risk of ‘chemicals’ or 
‘gases’. Health risk varies with chemical composition, but also differs between 
materials with the same chemistry. For example, one type of nanomaterial which has 
caused concern is carbon nanotubes (CNTs), largely because of their fibre like 
structure and their bio persistence, factors which they share with asbestos. Carbon in 
the form of carbon black, by comparison, has a very different structure. It has been 
used in tyres for around 100 years and is considered to be one of the lower risk 
nanomaterials, carrying toxicity comparable to that of other respirable dusts. 
CNTs themselves show wide variation – they may be single walled (a single, rolled 
sheet of graphene, with a diameter of around 1 nm) or multi walled (multiple tubes 
inside one another, and a diameter between 2 and 100 nm). They may also be short 
(<5 µm in length) or long (typically 5-50 µm but potentially much longer); straight or 
tangled; and may or may not encapsulate additional substances such as heavy metals. 
All of these characteristics influence toxicity, and there is similar variation for other 
nanomaterials. For example silica (silicon dioxide) exists in two forms – crystalline, 
which is found in its non-nano form in cementitous products and is a major cause of 
ill-health in the construction industry; and amorphous which is a less hazardous 
material, and is the form more commonly used at nanoscale proportions (for example 
as ‘silica fume’ used in many high performing mortars and concretes). Other materials 
such as titanium also exist in multiple forms. The hazardousness of each nanomaterial 
can therefore be influenced by many characteristics including size, shape, solubility, 
aggregation state (whether and how the particles clump together), surface charge, and 
many other factors. This makes it difficult to draw firm conclusions regarding health 
effects, particularly as many health risk studies do not describe the nanoparticles used 
to this level of detail. Consequently, many authorities, including the HSE in the UK 
advocate a precautionary approach – in the absence of evidence that nanomaterials are 
safe, action should be taken to avoid harm which could plausibly occur. 
Applying this approach to construction management is made difficult by uncertainties 
over which nanomaterials might be used and where. Most products which contain 
nanomaterials are not required to be labelled as such, and safety data sheets do not 
typically include this level of detail. Our current study initially identified around 150 
products which were believed to contain nanomaterials (based, for example, on the 
name, properties or description of the product, or on manufacturers’ claims). We have 
tested 20 of these so far and found that 16 contain either a small or very small number 
of nanoparticles and the remaining four contain none. A database in the United States 
(CPWR 2015) has identified around 400 construction products which might be nano-
enabled based upon similar criteria, but is unable to identify the nanomaterial 
supposedly contained in most of these. 
This lack of clarity is uncomfortable and it is important that research continues to 
identify more conclusively the hazardousness of the particular nanomaterials  which 
are most likely to be found in construction products. However, the uncertainty needs 
to be considered in context. There are significant risks already present in the 
construction industry, including silica dust, sensitising agents and solvents; whilst the 
literature so far has failed to show significant evidence of harm for most 
nanomaterials, with the exception of quantum dots (which are unlikely to be used in 
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construction) and carbon nanotubes (Krug 2014). Good implementation of standard 
control measures (such as ventilation and extraction systems, high standards of 
hygiene and welfare, and provision of suitable protective equipment when necessary) 
remain the most effective route to protect against the known hazards in the industry  
as well as new (or unrecognised) hazards, in the absence of evidence to the contrary. 
ASSESSING EXPOSURE TO NANOMATERIALS  
To understand the risks which might arise from the use of nanotechnology, we need a 
good understanding not just of how hazardous particular materials are, but also what 
the potential is for exposure in construction. We need to know the quantities of 
materials being used and the likelihood of particle release at various stages of a 
building’s life – construction, maintenance and modification, demolition, and 
recycling. Unfortunately, the evidence regarding potential exposure to nanomaterials 
is even less substantial and conclusive than that relating to their hazard profile 
(Savolainen et al. 2010). 
Assessment of particle release needs to be performed on real construction products, as 
it is influenced by many factors such as the nature and quality of the materials 
themselves and the matrix in which the nanomaterials are contained, as well as the 
methods and tools used. Planning such experiments is made more difficult by the lack 
of certainty over which products are nano-enabled. 
A particular issue in exposure assessment is how to take account of degradation over 
time. Epoxy resins, often used in paints and coatings for example, can break down 
under the influence of ultra violet light, potentially leading to embedded particles 
being more easily released from the matrix that they are secured in. There is evidence 
that the combination of weathering and machining processes (as might occur from 
sanding or drilling) can lead to free CNTs being released from composite materials 
(Hirth et al. 2013). This is of particular concern in demolition where materials may 
have been exposed to the elements for many years, but it is difficult and expensive to 
replicate these processes accurately in a laboratory environment. 
Finally, there are challenges regarding the actual measurement of nanoparticle release, 
particularly differentiating between released particles and background levels. 
Broekhuizen (2011) measured particle release from a task involving the drilling of 
nano-enabled concrete but found that cigarette smoking in the vicinity had a far higher 
impact on particle counts. Also, nanoparticles may be released from products even 
though they were not added during manufacture. For example, the demolition of 
ordinary (non-nano) concrete results in the release of particles of all sizes, including a 
high proportion of nano sized ones (Kumar and Morawska 2014). Again, this 
emphasises the importance of those working in construction continuing to implement 
good practices to protect workers against both the familiar and unknown risks.  
It is essential that constructors keep accurate records of the products used in their 
buildings, for example using the health and safety file required under the UK’s 
Construction (Design and Management) Regulations (2015). This will make risk 
assessment easier for those who modify or demolish the buildings in future years, 
once more detailed guidance is available. However, for such guidance to be produced 
in due course, action at a national and international level will be important. Firstly, 
improved labelling of products would make it easier to identify candidate materials for 
exposure testing, and also to understand the potential for exposure more widely. The 
EU is currently consulting on possible changes to REACH legislation (Registration, 
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Evaluation, Authorisation and Restriction of Chemicals, 2007) to improve the 
availability of information to those who use nano-enabled products. There is 
reluctance within the EU to introduce legislation specific to nano-labelling and 
registration, although France, Belgium and Denmark have all introduced their own 
(widely varying) regulations to this effect (Bochon 2015), all of which may contribute 
to increased availability of information about the extent of usage. In addition, it is 
important that ongoing and future research considers exposure potential and particle 
release from real construction products during standard building processes. For those 
working in demolition, the results of testing which includes weathering and life cycle 
approaches are particularly important. 
BALANCING RISK AND BENEFIT  
As a society we are familiar with the concept of balancing benefit and risk. Drugs with 
severe side effects are approved, but only for use in life threatening diseases; the 
armed forces prepare their recruits for battle situations using rigorous training 
methods unlikely to be considered acceptable in other sectors. In construction too 
these judgements are made – paint with a slightly higher level of toxicity might be 
used if it lasts twice as long as a safer product, and thus will reduce the need for 
repainting. Decisions are sometimes made in construction which are more 
questionable, for example working at height without proper fall protection, to enable 
work to proceed more quickly and cheaply: but at a high risk for those doing the work. 
Similar judgements are important with nanomaterials. Nanosilver is a material which 
has antimicrobial properties and can be used to reduce infection spread in hospitals 
and care homes. However, it might also have environmental effects as a consequence 
of its toxicity to microbes, and it may encourage the development of resistant 
microorganisms. An EU opinion (SCENIHR 2014) notes that there is a gap in our 
knowledge and observes that some in the peer-reviewed literature recommend usage  
be limited until this is  addressed, particularly in consumer products (such as washing 
machines, socks and house paints) where the benefits are less tangible. 
Construction is often a conservative industry, favouring methods and materials with 
proven reliability and longevity over new products and processes. Cost is also a key 
driver and this too has the potential to slow the introduction of new materials 
regardless of their apparent benefits. However, societal pressures can influence the 
adoption of new practices. For example in the current work we found a growing use of 
nano-coatings on windows in response to requirements for greater thermal efficiency 
of buildings. Other nano-enabled construction products might also contribute to 
reduced environmental impact such as concretes which use less energy and raw 
material in production. It is possible therefore, that higher risks from some materials 
may be tolerated in future if climate change concerns increase and have a greater 
influence on priorities. It is important that any such decisions are made based on a full 
understanding of the facts regarding both the benefits and the risks. 
Responsibilities for balancing benefit and risk also lie with designers and 
manufacturers of new nanomaterials: they need to consider this at an early stage, and 
throughout the development process. An EU-funded project (LICARA, Som et al. 
2014) recommends that where benefits outweigh risks, development can proceed; 
where benefits and risks are balanced, steps need to be taken to improve the benefits 
or to control the risks; and where risks are high, development should not generally 
proceed, however great the benefits. 
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TEMPERING INNOVATION WITH CAUTION - ISSUES OF 
TIMING 
Health and safety risk from new materials and processes should be addressed early to 
ensure that any risks are properly understood before they are introduced on a 
widespread basis. History contains numerous examples of hazardous materials being 
identified only in retrospect, when those working with certain substances developed 
particular diseases. Examples in construction include Chromium VI, lead paints and of 
course asbestos; examples in wider society include tobacco, ‘trans fats’ in foods, and 
environmental pollutants such as chlorofluorocarbons (CFCs).  
There is little doubt that nanomaterials are being used in the construction industry and 
that this is likely to increase - it has been suggested that 50% of building products are 
likely to be nano-enabled by the year 2025 (AECOM 2014). It is arguable whether 
this expansion is advisable, given the lack of clarity over the materials in use and the 
difficulties in predicting the potentials for exposure. The issue of timing is well 
illustrated by the addition of CNTs to concrete - in the early stages of our study it 
appeared from the academic literature that this was potentially quite widespread, 
taking advantage of the strengthening and electrically conductive characteristics of the 
nanomaterial.  This was concerning given the evidence that some forms of CNT are 
particularly hazardous, and the lack of information regarding exposure potential 
during the various stages of demolition. It appeared that the technology had 
progressed without adequate assessment of the risks, and without consideration of the 
control measures which might be appropriate. However, it became apparent 
subsequently that the high cost and practical challenges associated with CNTs had 
delayed their transition from laboratory to industry. Only in recent months have there 
been reports that field testing of CNT-enhanced concrete is taking place with a view to 
commercialisation in 2016 (Eden Energy 2014); therefore testing is required now to 
improve understanding of their risk profile throughout the life cycle of the product and 
to provide proper guidance to those who might work with them.  
It is perhaps inevitable that the use of nanotechnology will continue to develop ahead 
of detailed information on the hazards of specific materials. As discussed above, the 
best solution for those working in construction is to adopt a precautionary approach, 
typically involving the control methods already used to manage known hazards in the 
industry. More sophisticated risk assessment will become possible as the data become 
clearer, enabling better distinction between those materials which might or might not 
give real cause for concern. For example, some characteristics of nanomaterials such 
as being fibre shaped make them more hazardous, and others such as being soluble 
make them less so. Work is ongoing to refine such methods for use in nanotechnology 
(Bergamaschi et al. 2015). Guidance specific to the use of nanomaterials in the 
construction industry is also expected to be published shortly by SCAFFOLD. This is 
a large European project which has assessed the risks of nanomaterials and the 
potential of exposure during construction and maintenance tasks.  
RESPONSIBILITIES FOR RISK ASSESSMENT OF NEW 
MATERIALS  
There are legal requirements for manufacturers to gather information on the health and 
safety risks of their products. Under REACH in Europe, for example, manufacturers 
are required to assess and manage the risk from the materials that they sell and to 
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provide appropriate information for their users through safety data sheets. Similar 
provisions apply in other countries such as the United States. 
It could also be argued that manufacturers have a moral duty to ensure the safety of 
the products that they market, and to share the relevant data with their customers. For 
example, Responsible Research and Innovation is an EU approach which expects 
business to work with researchers and the public to ensure that the needs of all parties 
are aligned (Sutcliffe 2011). There is evidence that some companies recognise this 
responsibility. For example Bayer (who developed ‘Baytubes’, one of the early CNT 
products) states on its website, 'we assess the possible health and environmental risks 
of a product along the entire value chain. This starts with research and development 
and continues through production, marketing and use by the customer through to 
disposal' (Bayer 2015).  
In reality it is difficult to evaluate how companies make such judgements, and how 
they balance these legal and social responsibilities with accountability to their 
shareholders. For example, the Australian/American company which has started 
trialling CNT-enhanced concrete reports that it has ‘resolved’ health and safety 
concerns through the inclusion of the CNT in a ‘liquid admixture’ and by using only a 
low percentage in its product (Eden Energy 2014). This in itself is not evidence that 
the material will be safe at various stages of use, although further information may 
become available before the product reaches commercialisation.  
Independent testing of materials ensures a degree of neutrality and provides 
confidence and reassurance. It is also able to address broader issues rather than being 
limited to individual products; and findings can be made publically available, without 
the confidentiality concerns which may inevitably arise at a company level. Thus the 
EU has spent around €5bn on nano-technology research for the period 2002-2013, 
including a range of studies specifically addressing health and safety concerns (e.g. 
Scaffold, NanoMicex, Sanowork, Marina and NanoReg); and the United States 
committed €15bn over a similar period. However, it can be challenging to undertake 
testing on targeted products. During our research it has proved difficult to obtain 
samples of many nano-enabled construction products, particularly those which are 
sold only to professional users. Some companies have requested non-disclosure 
agreements; others have simply ignored requests to participate in the research. 
There is little that construction mangers can do to directly influence the research 
agenda at this stage. It is to be hoped that assessment of nano-safety risk will continue 
at all levels including life cycle studies to take account of the long term risk, the 
impact of weathering etc. At the same time, improved transparency by producers of 
new materials will make it easier to interpret and act on research which has been 
published. For example, data which show the risk profile for silicon dioxide or 
titanium dioxide are of limited value if poor labelling makes it difficult to identify 
products which might contain them. 
FUNDING OF RESEARCH AND DEVELOPMENT 
This question is linked to the previous one: there are potentially high costs associated 
with evaluating health risks from new products. This may be problematic where small 
companies are involved in developing a material or product, and may be reluctant (or 
unable) to commit the necessary resource until they are confident that a product is 
commercially viable. There is some evidence from France, where all nanomaterials 
are required to be registered centrally, that this could adversely affect the innovation 
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and development of nanomaterials. The reported costs of registration (including 
characterisation of nanomaterials in terms of size, shape etc) are around €15 000 per 
company and some French companies report being asked by partners specifically to 
provide ‘non-nano’ products in order to avoid these costs (RPA et al 2014).  
Where costs are incurred by organisations, they will inevitably be passed on to 
customers. This has particular implications for the adoption of nanomaterials in 
construction given the high volumes of materials used and the strong focus in the 
industry on price and value.  
MAKING INFORMATION AVAILABLE  
The importance of engaging the public in research outcomes and innovation is a 
strong theme in Europe, seen for example in funding calls from the EU and other 
research bodies such as the ESPRC. There is a benefit in sharing research in this way; 
in the absence of good information, those with concerns may draw their own, 
potentially erroneous, conclusions. Such misinformation has been suggested for 
example, as one possible reason for the failure of Europe to accept genetically 
modified (GM) products (Sutcliffe 2011). 
Our interviews revealed very limited awareness of nanomaterials amongst those either 
working in construction and demolition or those selling building products. A similar 
situation has been reported in Europe and the United States, with less than half of 
those potentially working with nanomaterials in construction being aware of this (van 
Broekhuizen and van Broekhuizen 2009; Lippy 2015). In practice, there is limited 
benefit in managers and workers in construction knowing simply whether or not 
particular products are nano-enabled, given the lack of clarity over what this really 
means in health terms. More important is that those who carry out risk assessment in 
construction are able to rely on the data provided, for example in safety data sheets. A 
priority, therefore, should be for material producers and sellers to know that their 
products are nano-enabled, and to ensure that data sheets are comprehensive, accurate, 
and based on the most current findings regarding nanomaterial hazard. ISO guidance 
is available to support them in this (ISO 2012).   
Centralised data collection is also a good way forward, assessing risk at an industry 
level, and then converting it into user-friendly tools for employers and workers. This 
is the approach of the current research, and also that taken by the SCAFFOLD project 
mentioned earlier, which will shortly publish an on-line risk assessment tool for those 
working in construction.  
CONCLUSIONS  
Nanotechnology is offering exciting opportunities and providing industry with new 
materials and better performance from existing materials. Construction is one of many 
areas where there could be great benefit. However, there are concerns regarding 
potential health risk, and although the knowledge base is developing steadily it is not 
yet complete. Therefore it is still necessary to adopt a precautionary approach. Health 
risk for construction workers is particularly difficult to assess, as products are rarely 
labelled and minimal (or no) information on material composition is provided in many 
cases. There is even less evidence regarding the potential for exposure, particularly in 
demolition where it is important to consider the impact of long-term degradation as 
well as the effects of aggressive demolition techniques. 
The health risks of nanomaterials 
517 
 
Those managing construction and demolition should adopt best practice in health and 
safety to protect workers against existing hazards such as silica dust and a variety of 
irritants and allergens. These remain important hazards regardless of the introduction 
of new materials, and similar protective methods are likely to be effective in both 
cases. However, there is also scope for constructors to ask challenging questions of 
their suppliers, to encourage them to understand better the products that they supply 
and to ensure that safety data sheets for nanomaterials are comprehensive, accurate 
and appropriate. 
As nanotechnology has advanced over the last 15-20 years and change continues to 
accelerate, the information we need to adequately assess and manage risk has failed to 
develop at the same rate. The same challenges are likely to apply to other processes 
and materials outside nanotechnology, as developers seek new ways to innovate and 
differentiate themselves from their competitors. It is unlikely that legislation will be 
able to keep up with these changes, so designers and developers of new materials must 
take responsibility for ensuring that the potential risks of these products are properly 
evaluated and kept under review as new data emerge. 
Centrally funded investigation will continue to be important to ensure that such work 
is comprehensive; and to hold industry to account and ensure that commercial 
interests are not allowed to take precedence over health and/or safety. There is also an 
important role for governments and industry bodies to draw together findings from 
various sources, identify common themes, and translate technical data into user-
friendly guidance. This combination of approaches provides the best chance that we 
can adopt nanomaterials and other new technologies in a safe and successful manner 
whilst ensuring that disproportionate anxiety and lack of understanding do not detract 
from the process and reduce innovation. 
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